FiercePharmaAsia—Takeda’s $2.3B Japan consumer health sale; Bayer’s new Beijing plant; Celltrion’s latest biosim pact

FiercePharmaAsia—Takeda’s $2.3B Japan consumer health sale; Bayer’s new Beijing plant; Celltrion’s latest biosim pact
chelfand
Fri, 08/28/2020 – 11:40